Immunovant IMVT Balance Sheet

Income Statement

Quarter End	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	515.56M	458.66M	428.15M	456.24M	405.84M	351.22M	292.07M	711.45M
Total Current Assets	512.93M	456.3M	426.09M	454.42M	404.33M	350.02M	291.18M	710.78M
Cash and Equivalents	493.82M	427.21M	405.77M	432.61M	376.53M	329.96M	269.93M	690.94M
Total Non-Current Assets	2.63M	2.35M	2.06M	1.82M	1.51M	1.21M	893k	670k
Total Liabilities	45.74M	22.16M	32.4M	41.57M	43.34M	51.36M	40.26M	32.1M
Total Current Liabilities	44.52M	21.24M	31.78M	41.26M	43.3M	51.36M	40.26M	32.1M
Total Non-Current Liabilities	1.22M	919k	614k	306k	47k	0	0	0
Common Equity	12k	12k	12k	13k	13k	13k	13k	14k
Retained Earnings	-355.39M	-395.76M	-443.69M	-506.92M	-566.35M	-640.28M	-698.95M	-750.36M

Year End March 30 2023	2018	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	405k	109.39M	412.49M	515.56M	405.84M
Total Current Assets	325k	109.08M	409.01M	512.93M	404.33M
Cash and Equivalents	325k	100.57M	400.15M	493.82M	376.53M
Total Non-Current Assets	25k	94.07M	391.48M	469.83M	362.49M
Total Liabilities	380k	15.32M	21.01M	45.74M	43.34M
Total Current Liabilities	380k	15.32M	18.77M	44.52M	43.3M
Total Non-Current Liabilities	0	0	2.24M	1.22M	47k
Total Equity	25k	94.07M	391.48M	469.83M	362.49M
Common Equity	0	5k	10k	12k	13k
Retained Earnings	0	-91.23M	-198.66M	-355.39M	-566.35M